Search research articles
Contact Us
Filters
Showing results (61-70 of 176) with videos related to
Page
of 18
Sort By:
Neuropsychologia
|
January 19, 2011
Attentional modulation of external speech attribution in patients with hallucinations and delusions
Lana Marija Ilankovic, Paul P Allen, Rolf Engel, et al.
Schizophrenia Research
|
November 14, 2003
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity
Georg Juckel, Jürgen Gallinat, Michael Riedel, et al.
Schizophrenia Research
|
January 17, 2015
Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: a randomised, double-blind, crossover study (eXtRa)
Michael Riedel, Margot Schmitz, Peter Kåre Østergaard, et al.
Planta
|
July 11, 2015
Water loss from litchi (Litchi chinensis) and longan (Dimocarpus longan) fruits is biphasic and controlled by a complex pericarpal transpiration barrier
Markus Riederer, Katja Arand, Markus Burghardt, et al.
International Journal of Bipolar Disorders
|
December 16, 2014
Do current screening recommendations allow for early detection of lithium-induced hyperparathyroidism in patients with bipolar disorder?
Michael Berger, Michael Riedel, Nora Tomova, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 16, 2014
Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability
Anna-Maria Kasparbauer, Dan Rujescu, Michael Riedel, et al.
Neuroscience Research
|
October 4, 2011
Monocytic HLA DR antigens in schizophrenic patients
Daniela Krause, Jenny Wagner, Judith Matz, et al.
Psychiatrische Praxis
|
July 23, 2013
[Risk factors for inpatient suicide]
Martin Lieb, Ulrich Palm, Sebastian Meyer, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 3, 2004
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy
Norbert Müller, Markus Ulmschneider, Constanze Scheppach, et al.
Journal of Clinical Pharmacology
|
February 22, 2013
Driving ability according to German guidelines in stabilized bipolar I and II outpatients receiving lithium or lamotrigine
Felix M Segmiller, Igor Hermisson, Michael Riedel, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 176) with videos related to
Sort By:
Page
of 18
Neuropsychologia
|
January 19, 2011
Attentional modulation of external speech attribution in patients with hallucinations and delusions
Lana Marija Ilankovic, Paul P Allen, Rolf Engel, et al.
Schizophrenia Research
|
November 14, 2003
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity
Georg Juckel, Jürgen Gallinat, Michael Riedel, et al.
Schizophrenia Research
|
January 17, 2015
Comparison of the effects of quetiapine extended-release and quetiapine immediate-release on cognitive performance, sedation and patient satisfaction in patients with schizophrenia: a randomised, double-blind, crossover study (eXtRa)
Michael Riedel, Margot Schmitz, Peter Kåre Østergaard, et al.
Planta
|
July 11, 2015
Water loss from litchi (Litchi chinensis) and longan (Dimocarpus longan) fruits is biphasic and controlled by a complex pericarpal transpiration barrier
Markus Riederer, Katja Arand, Markus Burghardt, et al.
International Journal of Bipolar Disorders
|
December 16, 2014
Do current screening recommendations allow for early detection of lithium-induced hyperparathyroidism in patients with bipolar disorder?
Michael Berger, Michael Riedel, Nora Tomova, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 16, 2014
Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability
Anna-Maria Kasparbauer, Dan Rujescu, Michael Riedel, et al.
Neuroscience Research
|
October 4, 2011
Monocytic HLA DR antigens in schizophrenic patients
Daniela Krause, Jenny Wagner, Judith Matz, et al.
Psychiatrische Praxis
|
July 23, 2013
[Risk factors for inpatient suicide]
Martin Lieb, Ulrich Palm, Sebastian Meyer, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 3, 2004
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy
Norbert Müller, Markus Ulmschneider, Constanze Scheppach, et al.
Journal of Clinical Pharmacology
|
February 22, 2013
Driving ability according to German guidelines in stabilized bipolar I and II outpatients receiving lithium or lamotrigine
Felix M Segmiller, Igor Hermisson, Michael Riedel, et al.
Page
of 18